Ryan Watts Net Worth & Insider Trades

Ryan Watts - President and CEO, Denali Therapeutics Inc

As of August 23, 2022

What is Ryan Watts's Net Worth?

The current estimated net worth of Denali Therapeutics Inc's President and CEO, Ryan Watts, is estimated to be about $26.68M . Ryan Watts owns about 2,368,187 units of Denali Therapeutics Inc common stock. In the last 5 years at Denali Therapeutics Inc, Ryan Watts has sold an estimated value of $26.15M worth.

What is Ryan Watts's Past Insider Trading?

Ryan Watts's largest purchase order was 70,749 units , worth over $399.98K on February 11, 2022. Ryan Watts's largest sale order was 88,334 units , worth over $6.62M on January 6, 2021. In total, Ryan Watts has made about 42 transactions over 5 years of their time at Denali Therapeutics Inc. Ryan Watts usually trades in February, with the busiest year in 2021. The most recent transaction was a sale order of 2,404 units , worth over $79.86K on August 23, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Ryan Watts's Salary in 2020?

As President and CEO of Denali Therapeutics Inc, Ryan Watts has a total base salary of $589,472 . Ryan Watts received compensation valued at about $9,302,445 in 2020 after becoming President and CEO. The vast majority of their compensation came in the form of a bonus of $648,419 , stock awards of $2,596,305 , option awards of $5,456,849 , and other compensation of $11,400 .

What is Ryan Watts's' Mailing Address?

  • Mailing address is C/o Denali Therapeutics Inc. 151 Oyster Point Blvd., 2nd Floor South San Francisco CA 94080 CA

Denali Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Ryan J. Watts, Ph.D. 2020 $589,472 $648,419 $2,596,305 $5,456,849 $11,400 $9,302,445
Ryan J. Watts, Ph.D. 2019 $566,800 $311,740 $838,168 $3,252,452 $9,447 $4,978,607
Ryan J. Watts, Ph.D. 2018 $545,000 $524,563 - $4,914,360 - $5,983,923
Alexander O. Schuth, M.D. 2020 $449,400 $359,520 $1,364,638 $2,018,444 $11,400 $4,203,402
Alexander O. Schuth, M.D. 2019 $428,000 $171,200 $305,830 $1,558,941 $12,657 $2,476,628
Alexander O. Schuth, M.D. 2018 $400,000 $355,000 $179,673 $2,948,616 $18,500 $3,901,789
Steve E. Krognes 2020 $484,200 $387,362 $1,364,638 $2,018,444 $11,400 $4,266,044
Steve E. Krognes 2019 $470,057 $188,023 $305,830 $1,558,941 $7,834 $2,530,685
Steve E. Krognes 2018 $455,260 $393,682 $179,673 $2,948,616 $24,000 $4,001,231
Carole Ho, M.D. 2020 $457,600 $366,080 $1,382,774 $2,107,493 $11,400 $4,325,347
Carole Ho, M.D. 2019 $440,000 $176,000 $305,830 $1,558,941 $8,800 $2,489,571
Carole Ho, M.D. 2018 $423,124 $371,187 $179,673 $2,948,616 $12,869 $3,935,469
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1714899/000171489921000042/fy20def14aproxy.htm

What are Denali Therapeutics Inc's Past Insider Trades?

Denali Therapeutics Inc's most recent insider trade came on August 25, 2022 by Marc Tessierlavigne who sold 20,000 units worth $632.28K . In the last 5 years, insiders at Denali Therapeutics Inc have sold an estimated value of $439.62M and bought an estimated value of $8M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Alexander Schuth, COFO and Secretary,  Ryan Watts, President and CEO,  and Carole Ho, Chief Medical Officer .

Denali Therapeutics Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1